← Back to guidelines
Palliative Care161 papers

Metastatic malignant neoplasm to intestinal tract

Last edited: 4/16/2026

Overview

Metastatic malignant neoplasms involving the intestinal tract represent advanced stages of cancer with significant implications for patient management, often necessitating palliative care interventions 1.

Diagnosis

  • Imaging studies (CT, MRI) essential for identifying metastatic lesions 1.
  • Endoscopy with biopsy confirms malignancy and histological subtype 1.
  • Laboratory tests (CBC, liver function tests) assess systemic involvement and organ function 1.
  • Management

  • Palliative care consultation recommended to improve quality of life and symptom management 1.
  • Symptom control: antiemetics for nausea, opioids for pain, and antidiarrheals for gastrointestinal symptoms 1.
  • Targeted therapy or chemotherapy may be considered based on primary tumor type and patient performance status 1.
  • Special Populations

  • No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.
  • Key Recommendations

  • Implement hospital-based palliative care teams to enhance consultation rates and improve end-of-life care quality (Evidence: Moderate) 1.
  • Regularly utilize imaging and endoscopic procedures for diagnosis and monitoring of metastatic disease progression (Evidence: Moderate) 1.
  • Integrate multidisciplinary symptom management strategies tailored to individual patient needs, emphasizing palliative care principles (Evidence: Expert opinion) 1.
  • References

    1 Demanelis AR, Keresztury J, Emmett M, Moss AH. The development and outcomes of a statewide network of hospital-based palliative care teams. Journal of palliative medicine 2005. link

    Original source

    1. [1]
      The development and outcomes of a statewide network of hospital-based palliative care teams.Demanelis AR, Keresztury J, Emmett M, Moss AH Journal of palliative medicine (2005)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG